Localization of neuroendocrine tumours with [111In]DTPA-octreotide scintigraphy (Octreoscan): A comparative study with CT and MR imaging

QJM: An International Journal of Medicine

Volumn 91, Issue 4, 1998, Pages 295-301

  Shi, W ^a   Johnston, C F ^a   Buchanan, K D ^a   Ferguson, W R ^b   Laird, J D ^b   Crothers, J G ^b   McIlrath, E M ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PENTETATE INDIUM IN 111; PENTETREOTIDE; SOMATOSTATIN RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOID; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE TUMOR; FEMALE; HUMAN; INTERMETHOD COMPARISON; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; MEDULLARY CARCINOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTIGRAPHY; ZOLLINGER ELLISON SYNDROME;

EID: 0031949612     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/91.4.295     Document Type: Article

References (30)

1. Solcia E, Capella C, Fiocca R, Cornaggia M, Bosi F. The gastroenteropancreatic endocrine system and related tumours. Gastroenterol Clin North Am 1989; 18:671-93.
2. Reinig JW, Dwyer AJ, Miller DL, White M, Frank JA, Sugarbaker PH, Chang AE, Doppman JL. Liver metastasis detection: comparative sensitivities of MR imaging and CT scanning. Radiology 1987; 162:43-7.
3. Chezmar JL, Nelson RC, Small WC, Bernardino ME. Magntic resonance imaging of the pancreas with gadolinium-DTPA. Gastrointest Radiol 1991; 16:139-42.
4. Wank SA, Doppman JL, Miller DL, Collen MJ, Maton PN, Vinayek R, Slaff JI, Norton JA, Gardner JD, Jensen RT. Prospective study of the ability of computed tomography to localize gastrinomas in patients with Zollinger-Eliison syndrome. Gastroenterology 1987; 92:905-12.
5. Steiner E, Stark DD, Hahn PF, Saini S, Simeone JF, Mueller PR, Wittenberg J, Ferrucci JT. Imaging of pancreatic neoplasms: comparision of MR and CT. Am J Roentgenol 1989; 152:487-91.
6. Semelke RC, Cumming MJ, Shoenut JP, Magro CM, Yaffe CS, Kroeker MA, Greenberg HM. Comparison of dynamic contrast-enhanced CT and MR imaging with dynamic Gadolinium enhancement and fat suppression. Radiology 1993; 186:799-802.
7. 111In-octreotide scintigraphy in oncology. Digestion 1993; 54(suppl 1):84-7.
8. Scherubl Bader M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riechen EO, Wiedenmann B. Somatostatin-receptor imaging of neuroendocrine gastroenterohepatic tumours. Gastroenterology 1993; 105:1705-9.
9. Bohuslavizki KH, Brenner W, Gunther M, Eberhardt J-U, Jahn N, Tinnemeyer S, Wolf H, Sippel C, Clausen M, Gatzemeier U, hense E. Somatostatin receptor scintigraphy in the staging of small cell lung cancer. Nucl Med Commun 1996; 17:191-6.
10. Zimmer T, Stolzel U, Bader M, Koppenhagen K, Hamm B, Buhr H, Riecken EO, Wiedenmann B. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996; 39:562-8.
11. Jamar F, Fiasse R, Norbert L, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumours: safety, efficacy and impact on patient management. J Nucl Med 1995; 36:542-9.
12. Kvols L, Brown M, O'Connor M, et al. Evaluation of radiolabeled somatostatin ananlogue (I-123 octreotide) in the detection and localization of carcinoid and islet tumours. Radiology 1993; 187:129-33.
13. Lamberts SWJ, Reubi JC, Krenning EP. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumours. Acta Oncol 1993; 32:167-70.
14. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumours, Eur J Nucl Med 1993; 20:283-92.
15. Carnaille B, Nocaudie M, Pattou F, Huglo D, Deveaux M, Marchandise X, Proye C. Scintiscans and carcinoid tumours. Surgery 1994; 116:1118-22.
16. Moyse E, Le Dafniet M, Epelbaum J, Pagesy P, Peillon K, Kordon C, Enjalbert A. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas. J Clin Endocrinol and Metabol 1985; 61:98.
17. Reubi JC, Krenning E, Lamberts SWJ, Kvols L. In vitro detection of Somatostatin receptors in'human tumours. Digestion 1993; 54(suppl 1):76-83.
18. Reubi JC, Kvols LK, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50:5969-77.
19. 1]-octreotide. Q J Med 1994; 87:83-8.
20. 111-labelled octreotide (Octreoscan). Q J Med 1996; 89:539-42.
21. Reubi JC, Kvols L, Krenning E, Lamberts SWJ. In vitro and In vivo detection of somatostatin receptors in human malignant tissues. Acta Oncologica 1991; 30:463-8.
22. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. Nuclear Med Annual 1995:1-50.
23. Raynor K, Murphy WA, Coy DH, Taylor JE, Moreau JP, Yasuda K, Bell Gl, Reisine T. Cloned Somatiostation receptors: identification of subtype-selective peptides and demonstration of high affinity-binding of linear peptides. Mol Pharmacol 1993; 43:838-44.
24. John M, Meyerhof W, Richter D, Waser B, Schaer JC, Scherübl H, er al. Positive soamtostatin receptor scintigraphy correlates with the presence of soamtostatin receptor subtype 2. Gut 1996; 38:33-9.
25. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 16:363-71.
26. Marx SJ, Spiegel AM, Levine MA, Rizzoli RE, Lasker RD, Santora AC, Downs RW Jr, Aurbach GD. Famial hypocalciuric hypercalciemia; the relation to primary parathyroid hyperplasia. N Engl J Med 1982; 307:416-26.
27. Thakker RV, Ponder BAJ. Multiple endocrine neoplasia. In: Sheppard MC, ed. Clinical Endocrinology and Metabolism. London, Bailliere Tindall, 1988:1031-67.
28. Eberle F, Grun R. Multiple endocrine neoplasia, type 1 (MEN 1). Ergebnisse der Innern medizin und Kinderheilkunde 1981; 46:76-149.
29. de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Leguludec D, Mignon M. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 1994; 21:1191-7.
30. Zimmer T, Ziegler K, Bader M, Fett U, Hamm B, Riecken EO, Wiedenmann B. Localization of neuroendocrine tumours of the upper gastrointestinal tract. Cut 1994; 35:471-5.